Increased periocular pigmentation with ocular hypotensive lipid use in African Americans [1]

American Journal of Ophthalmology

Volumn 137, Issue 4, 2004, Pages 783-

  Sodhi, Punita Kumari ^a   Verma, Lalit ^a   Ratan, Simmi K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; LATANOPROST; LIPID;

AFRICAN AMERICAN; GLAUCOMA; HUMAN; HYPERPIGMENTATION; INTRAOCULAR HYPOTENSION; IRRITANT DERMATITIS; LETTER; MELANOGENESIS; PRIORITY JOURNAL; SKIN COLOR;

EID: 1842608743     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)01513-7     Document Type: Letter

References (4)

1. Easthope S.E., Perry C.M. Topical bimatoprost A review of its use in open-angle glaucoma and ocular hypertension. Drugs Aging. 19:(3):2002;231-248.
2. Sodhi PK, Pandey RM, Ratan SK. Efficacy and safety of brimonidine, dorzolamide and latanoprost as adjunctive therapy in patients of primary open angle glaucoma: A randomized controlled trial. Int J Clin Pract 2003;57:875-878.
3. Wilkinson J.D., Willis C.M. Contact dermatitis Irritant. Vol 1. Champion R.H., Burton J.L., Burns D.A., Breathnach S.M. Textbook of Dermatology. 6th:1998;709-731 Blackwell Science, Oxford.
4. Sondergaard J., Greaves M.W., Jorgensen H.P. Recovery of prostaglandins in human primary irritant contact dermatitis. Arch Dermatol. 110:1974;556-558.